Souchet B, Audrain M, Billoir B, Lecanu L, Tada S, Braudeau J. Is it time to rethink the Alzheimer's disease drug development strategy by targeting its silent phase?. Neural Regen Res. 2018 Feb;13(2):224-225. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.